All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 6 of 206 pages ‹ First < 4 5 6 7 8 > Last ›
HSL19074
Mundy A
FDA Says Drug Firms Didn't Finish Follow-Ups
The Wall Street Journal 2011 Feb 9
http://online.wsj.com/article/SB10001424052748703313304576132560915752074.html
HSL19075
Taylor L
Senators seek action on 'unprecedented' drug shortages
PharmaTimes 2011 Feb 9
http://www.pharmatimes.com/Article/11-02-09/Senators_seek_action_on_“unprecedented”_drug_shortages.aspx
HSL19077
Lack of independent controls on clinical research
Center for Research on Multinational Corporation 2011 Feb 9
http://somo.nl/news-en/ethics-and-quality-of-drug-testing-in-low-income-countries-subject-to-additional-pressure-through-outsourcing/
HSL19095
Woodhead M
Health groups revealed as major political donors
6minutes.com 2011 Feb 9
http://www.6minutes.com.au/news/health-groups-revealed-as-major-political-donors
HSL19102
Stevens AJ, Jensen JJ, Wyller K, Kilgore PC, Chatterjee S, Rohrbaugh ML
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines
NEJM 2011 Feb 9;
http://healthpolicyandreform.nejm.org/?p=13730
HSL19071
Silverman E
The FDA Criteria For Going After Pharma Executives
Pharmalot 2011 Feb 8
http://www.pharmalot.com/2011/02/the-fda-criteria-for-going-after-pharma-executives/
HSL19073
Andrews CL
FDA Guidance Sheds Little Light On Criminal Liability From Park Doctrine Plea
Forbes Blog: On The Docket 2011 Feb 8
http://blogs.forbes.com/docket/2011/02/08/fda-guidance-sheds-little-light-on-criminal-liability-from-park-doctrine-plea/
HSL19076
Iskowitz M
DDMAC's Abrams gives update on policy making
Medical Marketing & Media 2011 Feb 8
http://www.mmm-online.com/ddmacs-abrams-gives-update-on-policy-making/article/195931/
HSL19079
Schneeweiss S, Avorn J
Postmarketing studies of drug safety
BMJ 2011 Feb 8;342:
http://www.bmj.com/content/342/bmj.d342.extract
HSL19080
Sweet M
Australian medical journal says no to drug industry advertising
BMJ 2011 Feb 8;342:
http://www.bmj.com/content/342/bmj.d884.extract
HSL19353
Roland M, Rao SR, Sibbald B, Hann M, Harrison S, Walter A, Guthrie B, Desroches C, Ferris TG, Campbell EG
Professional values and reported behaviours of doctors in the USA and UK: quantitative survey
BMJ 2011 Feb 7;
http://qualitysafety.bmj.com/content/early/2011/02/07/bmjqs.2010.048173.abstract
HSL19085
Silverman E
EU Trade Deal Could Cost Canada $3B For Drugs
Pharmalot 2011 Feb 7
http://www.pharmalot.com/2011/02/eu-trade-deal-could-cost-canada-3b-for-drugs/
HSL19086
Silverman E
Abbott Labs, Breastfeeding & A Baby Formula Survey
Pharmalot 2011 Feb 7
http://www.pharmalot.com/2011/02/abbott-labs-breastfeeding-a-baby-formula-survey/
HSL19087
Docs Speaking for Drug Companies on a Variety of Topics
PharmaLive 2011 Feb 7
http://pharmalive.com/news/index.cfm?articleID=759711
HSL19090
Taylor L
Europe, US 'using fake drugs crisis to boost pharma profits'
Pharma Times 2011 Feb 7
http://www.pharmatimes.com/Article/11-02-07/Europe_US_%E2%80%9Cusing_fake_drugs_crisis_to_boost_pharma_profits%E2%80%9D.aspx
HSL19210
Light DW, Warburton R
Demythologizing the high costs of pharmaceutical research
Bio Societies 2011 Feb 7;
http://www.palgrave-journals.com/biosoc/journal/vaop/ncurrent/abs/biosoc201040a.html
HSL19682
Dollars For Docs
NBC4 2011 Feb 7
http://www.youtube.com/watch?v=hCpyYTbsxUI
HSL19072
Walsh A
FDA Finally Releases 'Non-binding' Park Doctrine Criteria
FDA Law Blog 2011 Feb 6
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2011/02/fda-finally-releases-non-binding-park-doctrine-criteria.html
HSL19078
Mozes A
Uniform standards urged to help prevent consumer confusion about medication risks
Bloomberg Businessweek 2011 Feb 4
http://www.businessweek.com/lifestyle/content/healthday/649553.html
HSL19088
Silverman E
Feds Join Lawsuit Over Abbott Off-Label Marketing
Pharmalot 2011 Feb 4
http://www.pharmalot.com/2011/02/feds-join-lawsuit-over-abbott-off-label-marketing/
HSL19116
Brezis M, Wiist WH
Vulnerability of Health to Market Forces
Med Care 2011 Feb 4;
http://journals.lww.com/lww-medicalcare/Fulltext/publishahead/Vulnerability_of_Health_to_Market_Forces.99634.aspx
HSL19065
Rose D
Medical journal bans drug company ads
The Sydney Morning Herald 2011 Feb 3
http://news.smh.com.au/breaking-news-national/medical-journal-bans-drug-company-ads-20110203-1aev8.html
HSL19096
Hobson K
It’s Time to Cap Whistleblower Payments, Former Prosecutor Says
The Wall Street Journal Blog 2011 Feb 3
http://blogs.wsj.com/health/2011/02/03/its-time-to-cap-whistleblower-payments-former-prosecutor-says/
HSL19104
ImpactRx measures sales and marketing effectiveness in oncology offices.
Online PR News 2011 Feb 3
http://www.onlineprnews.com/news/103600-1296670323-impact-rx-releases-2010-oncology-promotion-report.html
HSL19062
Eye on the Ball: Medicines Regulation – not IP enforcement – can best deliver quality medicines
Oxfam International 2011 Feb 2
http://www.oxfam.org/en/policy/eye-ball
HSL19084
Moszynski P
New patent rules boost profits while safe drugs elude the world’s poor, says Oxfam
BMJ 2011 Feb 2;342:
http://www.bmj.com/content/342/bmj.d815.extract
HSL19125
Schneider J
Sanofi-Aventis Legal Attempt to Block Taxotere Generics in Australia Fails
Bloomberg News 2011 Feb 2
http://www.bloomberg.com/news/2011-02-02/sanofi-fails-to-block-sale-of-generic-cancer-drug-taxotere-in-australia.html
HSL19108
Scheib R
Film Review: Orgasm Inc.
Variety 2011 Feb 1
http://www.variety.com/review/VE1117944485?refcatid=31
HSL19064
Iheanacho I
Drug Tales and Other Stories: Definitely not acceptable: drug company sues journal over review
BMJ 2011 Feb 1;342:
http://www.bmj.com/content/342/bmj.d602.extract
HSL19126
Abruzzo J
Maximizing Targeting Efficiency For DTC Pharmaceutical Marketers
MediaPost Marketing: Health Blogs 2011 Feb 1
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=143920
HSL19154
Galato D, Pereira GB, Valgas C.
[Analysis of advertising material distributed through pharmacies and drugstores.]
Rev Saude Publica 2011 Feb;45:(1):212-215
HSL19425
Vacca C, Vargas C, Cañás M, Reveiz L
[Drug advertising and promotion: regulations and extent of compliance in five Latin American countries].
Rev Panam Salud Publica 2011 Feb;29:(2):76-83
http://www.scielosp.org/scielo.php?pid=S1020-49892011000200002&script=sci_abstract
HSL19144
Sales Through Retail Pharmacies (Twelve months to December 2010)
IMS Health 2011 Feb
http://view.respond.imshealth.com/?j=fe5815787d6405747d10&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037d73&s=fe21127975600c75701171&jb=ffcf14&ju=fe28167271610c7e711778&r=0
HSL19061
Corporate sponsorship linked to EU patient and consumer groups’ policy perspectives
HAI Europe 2011 Jan 31
http://www.haiweb.org/31012011/31%20Jan%202011%20HAI%20EUROPE%20Press%20Release%20Patient%20&%20consumer%20voice%20and%20pharmaceutical%20industry%20sponsorship.pdf
HSL19068
Lacasse JR, Leo J
Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research
BMC Research Notes 2011 Jan 31;4:27
http://www.biomedcentral.com/1756-0500/4/27/abstract
HSL19089
Which Pharma Product Websites are Driving Consumers to the Doctor to Request Prescriptions?
PharmaLive 2011 Jan 31
http://pharmalive.com/news/index.cfm?articleid=%20758040&categoryid=43
HSL19189
Gonon F, Bezard E, Boraud T
Misrepresentation of Neuroscience Data Might Give Rise to Misleading Conclusions in the Media: The Case of Attention Deficit Hyperactivity Disorder
PLoS One 2011 Jan 31;6:(1):e14618
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0014618
HSL19300
Eaton J, Lucas E, Donald D
Unproven for Older Women, Digital Mammography Saps Medicare Dollars
The Center For Public Integrity 2011 Jan 30
http://www.publicintegrity.org/articles/entry/2876/
HSL19128
Feeley J, Lawrence J
Pfizer to Pay $142.1 Million Over Neurontin Marketing
Bloomberg News 2011 Jan 29
http://www.bloomberg.com/news/2011-01-28/pfizer-ordered-to-pay-142-1-million-in-damages-over-neurontin-marketing.html
HSL19127
Novartis Pharmaceuticals Corporation Sentenced for Off-Label Drug Marketing
PharmaLive 2011 Jan 28
http://pharmalive.com/news/index.cfm?articleID=758198
HSL19136
Silverman E
St. Jude Whistleblower: ‘This Wasn’t Patient Care’
Pharmalot 2011 Jan 28
http://www.pharmalot.com/2011/01/st-jude-whistleblower-this-wasnt-patient-care/
HSL19253
Silverman E
Maryland Considers Banning Gifts To Doctors
Pharmalot 2011 Jan 27
http://www.pharmalot.com/2011/01/maryland-considers-banning-gifts-to-doctors/
HSL19058
Decollogny A, Eggli Y, Halfon P, Lufkin TM
Determinants of generic drug substitution in Switzerland
BMC Health Services Research 2011 Jan 26;11:17
http://www.biomedcentral.com/1472-6963/11/17/abstract
HSL19244
Arnold M
Boniva print ad hyped efficacy, says DDMAC
Medical Marketing & Media 2011 Jan 26
http://www.mmm-online.com/boniva-print-ad-hyped-efficacy-says-ddmac/article/195058/
HSL19254
Silverman E
Senators Reintroduce Pay-To-Delay Legislation
Pharmalot 2011 Jan 26
http://www.pharmalot.com/2011/01/senators-reintroduce-pay-to-delay-legislation/
HSL19255
Silverman E
The FDA And Its Pilot Pharma Fraud Program
Pharmalot 2011 Jan 26
http://www.pharmalot.com/2011/01/the-fda-and-its-pilot-pharma-fraud-program/
HSL19215
Bishop T
Lawmakers consider barring gifts to physicians
The Baltimore Sun 2011 Jan 26
http://www.baltimoresun.com/health/bs-md-stent-update-20110126,0,2975460.story
HSL19217
Loftus P
Glaxo Pulls Some Ads, Citing Image
The Wall Street Journal 2011 Jan 25
http://online.wsj.com/article/SB10001424052748703555804576102113367709694.html
HSL19227
Tattersall R
Marketing insulins
BMJ 2011 Jan 25;342:
http://www.bmj.com/content/342/bmj.d471.extract
HSL19019
Bayer, Baxter pay multimillion indemnity to haemophiliacs
Coalition against Bayer Dangers (Germany) 2011 Jan 24
HSL19016
Nagarajan R
MNC in secret pact with universities for food education
The Times of India 2011 Jan 24
http://timesofindia.indiatimes.com/india/MNC-in-secret-pact-with-universities-for-food-education/articleshow/7350233.cms
HSL19059
Kanamori Y, Malone RE
Conveying misinformation: Top-ranked Japanese books on tobacco
Tobacco Induced Diseases 2011 Jan 24;9:3
http://www.tobaccoinduceddiseases.com/content/9/1/3/abstract
HSL19081
Sanchís I
Las medicinas curan o causan cualquier enfermedad
Lavanguardia 2011 Jan 24
http://www.lavanguardia.es/lacontra/20110124/54105214595/las-medicinas-curan-o-causan-cualquier-enfermedad.html
HSL19188
Pfizer fined over Lipitor ads
Pharmacy Daily 2011 Jan 24
pharmacydaily.com.au
HSL19256
Silverman E
Should A Paxil Journal Article Be Retracted?
Pharmalot 2011 Jan 24
http://www.pharmalot.com/2011/01/should-a-paxil-journal-article-be-retracted/
HSL19216
Zajac A
Blowing the whistle on drug firms
The LA Times 2011 Jan 24
http://www.latimes.com/news/nationworld/nation/la-na-whistle-blower-20110124,0,5954723.story
HSL19017
Harris G
Federal Research Center Will Help Develop Medicines
The New York Times 2011 Jan 23
http://www.nytimes.com/2011/01/23/health/policy/23drug.html?_r=1
HSL19134
Mackert M, Love B, Holton AE
Journalism as Health Education: Media Coverage of a Nonbranded Pharma Web Site
Telemed J E Health 2011 Jan 23;
http://www.liebertonline.com/doi/abs/10.1089/tmj.2010.0127
HSL19218
Shaywitz D, Mammen M
The next killer app
The Boston Globe 2011 Jan 23
http://www.boston.com/bostonglobe/editorial_opinion/oped/articles/2011/01/23/the_next_killer_app/
HSL19015
France's Mediator° scandal: take the high road
Prescrire Int. 2011 Jan 21;
http://english.prescrire.org/en/81/168/46752/0/NewsDetails.aspx
HSL19171
Jack A
GSK’s US sales tactics undergo radical change
The Finanical Times 2011 Jan 21
http://www.ft.com/cms/s/0/42cc3cc8-2594-11e0-8258-00144feab49a.html#ixzz1EY16ss00
HSL19172
Edwards J
The iPad: Now Poised to Steal Drug Sales Reps’ Jobs
BNet 2011 Jan 20
http://www.bnet.com/blog/drug-business/the-ipad-now-poised-to-steal-drug-sales-reps-8217-jobs/7122
HSL19192
Taylor L
30% cut in Hungary's drug spending next month?
Pharma Times 2011 Jan 19
http://www.pharmatimes.com/Article/11-01-19/30_cut_in_Hungary_s_drug_spending_next_month.aspx
HSL19229
Kopp C
Say no to seeing sales reps
BMJ 2011 Jan 19;342:
http://www.bmj.com/content/342/bmj.d132.extract
HSL19143
Hassner Sharav V
Stop Retaliating Against Whistleblowers
Alliance for Human Research Protection 2011 Jan 19
http://www.ahrp.org/cms/content/view/754/9/
HSL19146
Chimonas S, Patterson L, Raveis VH, Rothman DJ
Managing Conflicts of Interest in Clinical Care: A National Survey of Policies at U.S. Medical Schools
Acad Med 2011 Jan 18;
http://journals.lww.com/academicmedicine/Abstract/publishahead/Managing_Conflicts_of_Interest_in_Clinical_Care__A.99895.aspx
HSL19174
White A, Bodoni S
Bayer Among Drug Firms in EU Probe of Patent Deals
Bloomberg Businessweek 2011 Jan 17
http://www.businessweek.com/news/2011-01-17/bayer-among-drug-firms-in-eu-probe-of-patent-deals.html
HSL19259
Silverman E
What 20 Years Of Pharma Fraud Has Wrought
Pharmalot 2011 Jan 17
http://www.pharmalot.com/2010/12/what-20-years-of-pharma-fraud-has-wrought/
HSL19262
Ramos J
Spotlight on Industry Ties of Health Advocacy Groups
Health Watch 2011 Jan 17
http://healthwatched.org/
HSL19013
Chazan D
France pledges reform after diabetes drug scandal
BBC News 2011 Jan 15
http://www.bbc.co.uk/news/world-europe-12200506
HSL19274
Unintended direct conflict between pharmaceutical marketing and public health
The Medical News 2011 Jan 14
http://www.news-medical.net/news/20110114/Unintended-direct-conflict-between-pharmaceutical-marketing-and-public-health.aspx
HSL19069
Dickinson JG
Life sciences waiting on social media rules
Medical Marketing & Media 2011 Jan 14
http://www.mmm-online.com/life-sciences-waiting-on-social-media-rules/article/194954/
HSL19149
Rothman SM, Raveis VH, Friedman A, Rothman DJ
Health Advocacy Organizations and the Pharmaceutical Industry: An Analysis of Disclosure Practices
Am J Public Health 2011 Jan 13;
http://ajph.aphapublications.org/cgi/content/short/AJPH.2010.300027v1
HSL19219
Wilson D
Study Finds Lack of Disclosure Among Advocacy Groups
The New York Times 2011 Jan 13
http://prescriptions.blogs.nytimes.com/2011/01/13/study-finds-lack-of-disclosure-among-advocacy-groups/
HSL19257
Silverman E
Should Health Advocacy Groups Disclose Funding?
Pharmalot 2011 Jan 13
http://www.pharmalot.com/2011/01/should-health-advocacy-groups-disclose-funding/
HSL19263
Wang M
Health Advocacy Groups Take Drug Company Cash—Often Without Full Disclosures, Report Says
ProPublica 2011 Jan 13
http://www.propublica.org/blog/item/health-advocacy-groups-take-drug-company-cashoften-without-full-disclosures
HSL19148
Brody H, Light DW
The Inverse Benefit Law: How Drug Marketing Undermines Patient Safety and Public Health.
Am J Public Health 2011 Jan 13;
http://ajph.aphapublications.org/cgi/content/short/AJPH.2010.199844v1
HSL19011
Tinari S, Häner H, Padrutt R
The Tamiflu Saga – A pandemic business
Falo and Rundschau : RSI and SF 1 2011 Jan 120
HSL19220
Taylor L
Drugmakers sue Czech govt over pricing, insurance moves
Pharma Times 2011 Jan 12
http://www.pharmatimes.com/Article/11-01-12/Drugmakers_sue_Czech_govt_over_pricing_insurance_moves.aspx
HSL19233
Chan A
Access to clinical trial data
BMJ 2011 Jan 12;342:
http://www.bmj.com/content/342/bmj.d80.extract
HSL19232
Jefferson T, Doshi P, Thompson M, Heneghan C
Ensuring safe and effective drugs: who can do what it takes?
BMJ 2011 Jan 11;342:
http://www.bmj.com/content/342/bmj.c7258.extract
HSL19234
Benkimoun P
French drug journal is sued for criticising Protopic’s licence extension
BMJ 2011 Jan 11;342:
http://www.bmj.com/content/342/bmj.d158.extract
HSL19283
Reddy KS, Patel V, Jha P, Paul VK, Kumar AS, Dandona L; for The Lancet India Group for Universal Healthcare.
Towards achievement of universal health care in India by 2020: a call to action.
Lancet 2011 Jan 11;
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736%2810%2961960-5
HSL19010
Jessop N
Will DTC Advertising Appear In Europe?
PharmTech 2011 Jan 7
http://pharmtech.findpharma.com/pharmtech/article/articleDetail.jsp?id=702161&sk=a4ba12396a7bcfa6e9f9b30a20534376
HSL19221
Kendall B
Court Takes Up Drug-Data Case
The Wall Street Journal 2011 Jan 7
http://online.wsj.com/article/SB10001424052748704055204576068260177082914.html
HSL19231
Smyth RMD, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists
BMJ 2011 Jan 6;342:
http://www.bmj.com/content/342/bmj.c7153.abstract
HSL19235
Moynihan R
Beware the fortune tellers peddling genetic tests
BMJ 2011 Jan 6;342:
http://www.bmj.com/content/342/bmj.c7233.extract
HSL19150
Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS
Increasing off-label use of antipsychotic medications in the United States, 1995-2008
Pharmacoepidemiol Drug Saf 2011 Jan 6;
http://onlinelibrary.wiley.com/doi/10.1002/pds.2082/abstract
HSL19258
Silverman E
When Reps Are Told To Sell ‘Gobs Of Dope’
Pharmalot 2011 Jan 5
http://www.pharmalot.com/2011/01/when-reps-are-told-to-sell-gobs-of-dope/
HSL19138
Un laboratoire attaque Prescrire
Le Figaro 2011 Jan 4
http://www.lefigaro.fr/flash-actu/2011/01/04/97001-20110104FILWWW00640-un-laboratoire-attaque-prescrire.php
HSL19236
Spence D
When marketing masquerades as education
BMJ 2011 Jan 4;342:
http://www.bmj.com/content/342/bmj.c7469.extract
HSL19152
Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK
Physician Perceptions About Generic Drugs (January)
Ann Pharmacother 2011 Jan 4;
http://www.theannals.com/cgi/content/full/45/1/31
HSL19445
There's no such thing as a free gift
The Sydney Morning Herald 2011 Jan 4
http://www.smh.com.au/opinion/editorial/theres-no-such-thing-as-a-free-gift-20110103-19dpd.html
HSL19444
Besser L
Regulator fails to keep register of drug company gifts
The Sydney Morning Herald 2011 Jan 3
http://www.smh.com.au/national/regulator-fails-to-keep-register-of-drug-company-gifts-20110102-19d2e.html
HSL19346
Rollinsa BL, Kingb K, Zinkhan G, Perri M
Nonbranded or Branded Direct-to-Consumer Prescription Drug Advertising—Which is More Effective?
Health Marketing Quarterly 2011 Jan 1;28:(1):86 - 98
http://www.informaworld.com/smpp/content~db=all~content=a933894806
HSL19347
Kim H
Pharmaceutical Companies as a Source of Health Information: A Pilot Study of the Effects of Source, Web Site Interactivity, and Involvement
Health Marketing Quarterly 2011 Jan;28:(1):57 - 85
http://www.informaworld.com/smpp/content~db=all~content=a933900963
HSL19012
Morelle A, Bensadon A-C, Marie E
Enquête sur le Mediator
La Documentation Francais 2011 Jan260
http://www.ladocumentationfrancaise.fr/rapports-publics/114000028/index.shtml
HSL19060
Jelinek GA, Brown AF.
A stand against drug company advertising.
Emerg Med Australas 2011;23:(1):4-6
doi: 10.1111/j.1742-6723.2010.01393.x. No abstract available.
http://onlinelibrary.wiley.com/doi/10.1111/j.1742-6723.2010.01393.x/full
HSL19118
Gagne JJ, Choudhry NK
How Many 'Me-Too' Drugs Is Too Many?
JAMA 2011 Jan;305:(7):711-712
http://jama.ama-assn.org/content/305/7/711.extract
HSL19157
Galizzi MM, Ghislandi S, Miraldo M
Effects of refer ence pricing in pharmaceutical markets: a review
Pharmacoeconomics 2011 Jan;29:(1):17-33
http://www.genericsamples.com/wp/effects-of-reference-pricing-in-pharmaceutical-markets-a-review/
Page 6 of 206 pages ‹ First < 4 5 6 7 8 > Last ›
